Covered recipient · General Payments record
SHANNON C EJIOFOR
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2022–2024
$948.93
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $747.90 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Retrophin, Inc. | $273.39 | 3 |
| CALLIDITAS THERAPEUTICS US INC. | $134.56 | 1 |
| Novo Nordisk AS | $109.85 | 1 |
| Aurinia Pharma U.S., Inc. | $89.57 | 1 |
| Mallinckrodt Hospital Products Inc. | $84.70 | 1 |
| CorMedix Inc. | $35.71 | 1 |
| Relypsa, Inc. | $20.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aurinia Pharma U.S., Inc. | $89.57 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150679563 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $134.56 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141525606 | CMS |
| CorMedix Inc. | $35.71 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082026062 | CMS |
| Mallinckrodt Hospital Products Inc. | $84.70 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145067867 | CMS |
| Novo Nordisk Inc | $109.85 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097152220 | CMS |
| Travere Therapeutics, Inc. | $124.97 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149915066 | CMS |
| Travere Therapeutics, Inc. | $123.24 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149915062 | CMS |
| Travere Therapeutics, Inc. | $25.18 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149915059 | CMS |
| Vifor Pharma, Inc. | $20.12 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124037309 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.